vs

Side-by-side financial comparison of CoastalSouth Bancshares, Inc. (COSO) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

OptimizeRx Corp is the larger business by last-quarter revenue ($32.2M vs $21.3M, roughly 1.5× CoastalSouth Bancshares, Inc.). CoastalSouth Bancshares, Inc. runs the higher net margin — 31.7% vs 15.6%, a 16.1% gap on every dollar of revenue. OptimizeRx Corp produced more free cash flow last quarter ($7.1M vs $-5.9M).

CoastalSouth Bancshares, Inc. is a U.S.-based regional bank holding company. It provides a full range of personal and commercial banking services including deposit accounts, consumer loans, mortgages, commercial financing and wealth management solutions for retail customers and small-to-medium enterprises across the U.S. Gulf Coast region.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

COSO vs OPRX — Head-to-Head

Bigger by revenue
OPRX
OPRX
1.5× larger
OPRX
$32.2M
$21.3M
COSO
Higher net margin
COSO
COSO
16.1% more per $
COSO
31.7%
15.6%
OPRX
More free cash flow
OPRX
OPRX
$13.0M more FCF
OPRX
$7.1M
$-5.9M
COSO

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
COSO
COSO
OPRX
OPRX
Revenue
$21.3M
$32.2M
Net Profit
$6.7M
$5.0M
Gross Margin
74.8%
Operating Margin
41.2%
26.6%
Net Margin
31.7%
15.6%
Revenue YoY
-0.2%
Net Profit YoY
6535.9%
EPS (diluted)
$0.54
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COSO
COSO
OPRX
OPRX
Q4 25
$32.2M
Q3 25
$21.3M
$26.1M
Q2 25
$19.9M
$29.2M
Q1 25
$21.9M
Q4 24
$32.3M
Q3 24
$21.3M
Q2 24
$18.8M
Q1 24
$19.7M
Net Profit
COSO
COSO
OPRX
OPRX
Q4 25
$5.0M
Q3 25
$6.7M
$779.0K
Q2 25
$6.0M
$1.5M
Q1 25
$-2.2M
Q4 24
$-78.0K
Q3 24
$-9.1M
Q2 24
$-4.0M
Q1 24
$-6.9M
Gross Margin
COSO
COSO
OPRX
OPRX
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
68.1%
Q3 24
63.1%
Q2 24
62.2%
Q1 24
62.0%
Operating Margin
COSO
COSO
OPRX
OPRX
Q4 25
26.6%
Q3 25
41.2%
7.9%
Q2 25
35.4%
10.9%
Q1 25
-9.6%
Q4 24
11.2%
Q3 24
-40.2%
Q2 24
-19.9%
Q1 24
-25.5%
Net Margin
COSO
COSO
OPRX
OPRX
Q4 25
15.6%
Q3 25
31.7%
3.0%
Q2 25
30.0%
5.2%
Q1 25
-10.0%
Q4 24
-0.2%
Q3 24
-42.8%
Q2 24
-21.3%
Q1 24
-35.0%
EPS (diluted)
COSO
COSO
OPRX
OPRX
Q4 25
$0.27
Q3 25
$0.54
$0.04
Q2 25
$0.57
$0.08
Q1 25
$-0.12
Q4 24
$0.00
Q3 24
$-0.50
Q2 24
$-0.22
Q1 24
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COSO
COSO
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$250.4M
$128.3M
Total Assets
$2.3B
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COSO
COSO
OPRX
OPRX
Q4 25
$23.4M
Q3 25
$19.5M
Q2 25
$16.6M
Q1 25
$16.6M
Q4 24
$13.4M
Q3 24
$16.1M
Q2 24
Q1 24
Total Debt
COSO
COSO
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
COSO
COSO
OPRX
OPRX
Q4 25
$128.3M
Q3 25
$250.4M
$122.3M
Q2 25
$209.4M
$119.3M
Q1 25
$116.3M
Q4 24
$117.0M
Q3 24
$114.5M
Q2 24
$121.0M
Q1 24
$122.5M
Total Assets
COSO
COSO
OPRX
OPRX
Q4 25
$176.9M
Q3 25
$2.3B
$170.3M
Q2 25
$2.2B
$169.3M
Q1 25
$167.8M
Q4 24
$171.2M
Q3 24
$165.2M
Q2 24
$172.9M
Q1 24
$176.4M
Debt / Equity
COSO
COSO
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COSO
COSO
OPRX
OPRX
Operating Cash FlowLast quarter
$-5.5M
$7.1M
Free Cash FlowOCF − Capex
$-5.9M
$7.1M
FCF MarginFCF / Revenue
-27.7%
22.0%
Capex IntensityCapex / Revenue
1.9%
0.0%
Cash ConversionOCF / Net Profit
-0.82×
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COSO
COSO
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$-5.5M
$3.2M
Q2 25
$-16.8M
$4.6M
Q1 25
$3.9M
Q4 24
$198.0K
Q3 24
$1.8M
Q2 24
$782.0K
Q1 24
$2.1M
Free Cash Flow
COSO
COSO
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$-5.9M
$3.2M
Q2 25
$-17.9M
$4.6M
Q1 25
$3.8M
Q4 24
$181.0K
Q3 24
$1.8M
Q2 24
$737.0K
Q1 24
$2.1M
FCF Margin
COSO
COSO
OPRX
OPRX
Q4 25
22.0%
Q3 25
-27.7%
12.2%
Q2 25
-90.3%
15.6%
Q1 25
17.5%
Q4 24
0.6%
Q3 24
8.3%
Q2 24
3.9%
Q1 24
10.6%
Capex Intensity
COSO
COSO
OPRX
OPRX
Q4 25
0.0%
Q3 25
1.9%
0.0%
Q2 25
5.5%
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
COSO
COSO
OPRX
OPRX
Q4 25
1.41×
Q3 25
-0.82×
4.11×
Q2 25
-2.82×
2.98×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons